Significant Increase in Short Interest for Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

On March 16th, 2025, it was reported that the Fidelity Disruptive Medicine ETF (NASDAQ:FMED) experienced a notable surge in short interest during February. As of February 28th, the total short interest had risen to 900 shares, marking an impressive increase of 125.0% compared to the previous total of 400 shares recorded on February 13th. This indicates that around 0.0% of the company's shares are sold short. With an average daily trading volume of 5,700 shares, the current short-interest ratio stands at 0.2 days.

Institutional Investments in Fidelity Disruptive Medicine ETF

In recent developments, an institutional investor has increased its stake in Fidelity Disruptive Medicine ETF. According to a recent 13F filing with the Securities and Exchange Commission, Jane Street Group LLC raised its ownership by an impressive 200.4% in the third quarter. The firm now holds 61,342 shares after purchasing an additional 40,924 shares during this period, representing about 2.92% of the Fidelity Disruptive Medicine ETF, valued at approximately $1,613,000 as of the latest reporting.

Fidelity Disruptive Medicine ETF Stock Performance

FMED opened at $24.03 this past Friday. The stock has seen a 12-month low of $23.32 and a high of $26.79. Additionally, the company maintains a fifty-day simple moving average of $25.50 and a 200-day simple moving average of $25.70. The current market capitalization of the ETF is $50.46 million, and it has a P/E ratio of 42.34 with a beta of 0.94.

Dividend Announcement by Fidelity Disruptive Medicine ETF

The firm has also recently announced a quarterly dividend, which was paid on December 24th. Record shareholders as of December 20th received a dividend of $0.112, with an ex-dividend date on December 20th as well. This reflects an annualized dividend payout of $0.45, yielding a dividend yield of 1.86%. This is a notable increase from the previous quarterly dividend of $0.00.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that primarily invests in healthcare equities. It is actively managed and focuses on companies engaging in disruptive innovations within the healthcare sector. The fund invests in the securities of both domestic and foreign issuers and was launched on April 16, 2020, with management by Fidelity.

Short, Interest, ETF